Trastuzumab Associated With Recurrent Severe Thrombocytopenia and Successful Use of Pertuzumab Monotherapy

Trastuzumab is a mainstay chemotherapeutic agent used in the treatment of human epidermal growth factor receptor 2 (HER2)/neu-positive breast cancer that, though generally well-tolerated, is classically associated with side effects like cardiotoxicity. Cytopenias can be seen but are generally second...

Descripción completa

Detalles Bibliográficos
Autores principales: Huff, Mallorie L, Kalter, Joshua A, Chase, Ramona E, Gupta, Ranju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890586/
https://www.ncbi.nlm.nih.gov/pubmed/35251819
http://dx.doi.org/10.7759/cureus.21748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890586/
https://www.ncbi.nlm.nih.gov/pubmed/35251819
http://dx.doi.org/10.7759/cureus.21748

Ejemplares similares